Role of BMIPP imaging for risk stratification in patients with coronary artery disease

Journal of Nuclear Cardiology

Volumn 12, Issue 2, 2005, Pages 148-150

  Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; FLUORODEOXYGLUCOSE; TECHNETIUM 99M; THALLIUM;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG UPTAKE; EDITORIAL; ENERGY METABOLISM; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

CLINICAL TRIALS; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; FATTY ACIDS; HUMANS; IODOBENZENES; MYOCARDIAL INFARCTION; PREVALENCE; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 16244418113     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2005.01.007     Document Type: Editorial

References (30)

1. H.J. Machulla M. Marsmann K. Dutschka Biochemical synthesis of a radioiodinated phenyl fatty acid for in vivo metabolic studies of the myocardium Eur J Nucl Med 5 1980 171-173
2. F.F. Knapp Jr M.M. Goodman A.P. Callahan G. Kirsch Radioiodinated 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid a useful new agent to evaluate myocardial fatty acid uptake J Nucl Med 27 1986 521-531
3. Y. Fujibayashi R. Nohara R. Hosokawa K. Okuda Y. Yonekura N. Tamaki et al., Metabolism and kinetics of iodine-123-BMIPP in canine myocardium J Nucl Med 37 1996 757-761
4. 123 I-BMIPP) Eur J Nucl Med 23 1996 383-389
5. 123I-labeled 15-p-iodophenyl-3-(R,S)-methyl-pentadecanoic acid (BMIPP) in perfused rat heart J Nucl Med 36 1995 1043-1050
6. R. Hosokawa R. Nohara Y. Fujibayashi K. Okuda M. Ogino T. Hata et al., Metabolic fate of iodine-123-BMIPP in canine myocardium after administration of etomoxir J Nucl Med 37 1996 1836-1840
7. Y. Fujibayashi Y. Yonekura Y. Takemura K. Wada K. Matsumoto N. Tamaki et al., Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration J Nucl Med 31 1990 1818-1822
8. R. Nohara K. Okuda M. Ogino R. Hosokawa N. Tamaki J. Konishi et al., Evaluation of myocardial viability with iodine-123-BMIPP in a canine model J Nucl Med 37 1996 1403-1407
9. N. Tamaki K. Morita Y. Kuge E. Tsukamoto The role of fatty acids in cardiac imaging J Nucl Med 41 2000 1525-1534
10. T. Mochizuki K. Murase H. Higashino et al., Ischemic "memory image" in acute myocardial infarction of 123I-BMIPP after reperfusion therapy a comparison with 99mTc-pyrophosphate and 201Tl dual-isotope SPECT Ann Nucl Med 8 2002 563-568
11. R. Tanaka T. Nakamura H. Kumamoto M. Miura K. Hirabayashi N. Okamato et al., Detection of stunned myocardium in post-reperfusion cases of acute myocardial infarction Ann Nucl Med 1 2003 53-60
12. Y. Takeishi S. Fujiwara H. Atsumi et al., Clinical significance of decreased myocardial uptake of 123 I-BMIPP in patients with stable effort angina pectoris Nucl Med Commun 16 1995 1002-1008
13. 123 I-BMIPP in patients with unstable angina pectoris comparison with perfusion imaging by 99mTc-sestamibi Ann Nucl Med 9 1995 125-130
14. M. Tateno N. Tamaki M. Yukihiro T. Kudoh N. Hattori E. Tadamura et al., Assessment of fatty acid uptake in patients with ischemic heart disease without myocardial infarction J Nucl Med 37 1996 1981-1985
15. A. Suzuki Y. Takada M. Nagasaka R. Kato T. Watanabe K. Shimokata et al., Comparison of resting β-methyl-iodophenyl pentadecanoic acid (BMIPP) and thallium-201 tomography using quantitative polar maps in patients with unstable angina Jpn Circ J 61 1997 133-138
16. 123I-BMIPP scintigraphy for detection of organic coronary stenosis and therapeutic outcome in patients with chest pain Ann Nucl Med 14 2000 187-192
17. Y. Kawai E. Tsukamoto Y. Nozaki K. Morita M. Sakurai N. Tamaki Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain J Am Coll Cardiol 38 2001 1888-1894
18. J.E. Udelson T.M. Bateman S.R. Bergmann et al., Proof of principle study of beta-methyl-p-[123I]-iodophenyl-pentadecanoic acid (BMIPP) for ischemic memory following demand ischemia [abstract] Circulation 108 2003 IV405
19. N. Tamaki E. Tadamura T. Kudoh N. Hattori Y. Yonekura R. Nohara et al., Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction Eur J Nucl Med 23 1996 272-279
20. T. Nakata T. Kobayashi N. Tamaki H. Kobayashi T. Wakabayashi S. Shimoshige et al., Prognosis value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction Nucl Med Commun 21 2000 897-906
21. T. Chikamori H. Fujita M. Nakasato M. Toba T. Nishimura Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease J Nucl Cardiol 12 2005 172-178
22. C. Kurata Y. Wakabayashi S. Shouda T. Mikami Y. Takei K. Tawarahara et al., Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP J Nucl Med 38 1997 1079-1084
23. N. Tamaki M. Kawamoto Y. Yonekura Y. Fujibayashi N. Takahashi J. Konishi et al., Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction assessment with emission tomography using an iodinated branched fatty acid J Nucl Med 33 1992 659-667
24. F. De Geeter P. Franken F.F. Knapp Jr A. Bossuyt Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction a study by means of Tc-99m sestamibi and iodine-123-beta-methyl iodophenyl pentadecanoic acid Eur J Nucl Med 21 1994 283-291
25. P. Franken F. De Geeter P. Dendale D. Demoor P. Block A. Bossuyt Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis correlation with wall motion and inotropic reserve J Nucl Med 35 1994 1758-1765
26. Y. Furutani T. Shiigi Y. Nakamura H. Nakamura M. Harada T. Yamamoto et al., Quantification of area at risk in acute myocardial infarction by tomographic imaging J Nucl Med 38 1997 1875-1882
27. 123I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction Eur J Nucl Med 25 1998 1390-1395
28. I. Matsunari T. Saga J. Taki Y. Akashi J. Hirai T. Wakasugi et al., Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction assessment with dynamic rest and stress images compared with stress thallium-201 SPECT J Nucl Med 35 1994 1279-1285
29. M. Kawamoto N. Tamaki Y. Yonekura E. Tadamura Y. Fujibayashi Y. Magata et al., Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium Ann Nucl Med 8 1994 47-54
30. T. Matsuki N. Tamaki T. Nakata A. Doi H. Takahashi M. Iwata et al., Prognostic value of fatty acid aimaging in patients with angina pectoris without prior myocardial infarction comparison with stress thallium imaging Eur J Nucl Med Mol Imaging 31 2004 1585-1591